PDE5A and skin cancer: In this study, while our focus did not encompass establishing causality between ﻿PDE5a inhibitors and skin cancer, we show that ﻿PDE5a inhibitor use is independently associated with skin cancer risk in individuals of European ancestries, and contributes to the high accuracy of our predictive model.